163 related articles for article (PubMed ID: 30075624)
1. Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2- a]pyrazin-3-ylethynyl)-4-isopropyl- N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2.
Wang Z; Zhang Y; Pinkas DM; Fox AE; Luo J; Huang H; Cui S; Xiang Q; Xu T; Xun Q; Zhu D; Tu Z; Ren X; Brekken RA; Bullock AN; Liang G; Ding K; Lu X
J Med Chem; 2018 Sep; 61(17):7977-7990. PubMed ID: 30075624
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Pyrazolo[3,4-
Tan X; Li C; Yang R; Zhao S; Li F; Li X; Chen L; Wan X; Liu X; Yang T; Tong X; Xu T; Cui R; Jiang H; Zhang S; Liu H; Zheng M
J Med Chem; 2022 Jan; 65(1):103-119. PubMed ID: 34821145
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Zhang Y; Bartual SG; Luo J; Xu T; Du W; Xun Q; Tu Z; Brekken RA; Ren X; Bullock AN; Liang G; Lu X; Ding K
ACS Med Chem Lett; 2017 Mar; 8(3):327-332. PubMed ID: 28337325
[TBL] [Abstract][Full Text] [Related]
5. 2-Amino-2,3-dihydro-1
Zhu D; Huang H; Pinkas DM; Luo J; Ganguly D; Fox AE; Arner E; Xiang Q; Tu ZC; Bullock AN; Brekken RA; Ding K; Lu X
J Med Chem; 2019 Aug; 62(16):7431-7444. PubMed ID: 31310125
[TBL] [Abstract][Full Text] [Related]
6. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
7. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models.
Yoshimori A; Asawa Y; Kawasaki E; Tasaka T; Matsuda S; Sekikawa T; Tanabe S; Neya M; Natsugari H; Kanai C
ChemMedChem; 2021 Mar; 16(6):955-958. PubMed ID: 33289306
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and bioactivity evaluation of 4-hydroxycoumarin derivatives as potential anti-inflammatory agents against acute lung injury and colitis.
Li X; Huang X; Zhao Y; Zheng Z; Guo M; Chen Z; Chen P; Li X; Liao J; Jiang M; Cho WJ; Cho YC; Zeng R; Tang Q; Liang G
Eur J Med Chem; 2024 Jun; 272():116487. PubMed ID: 38759452
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
12. Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Zhou Y; Liu T; Duan JX; Li P; Sun GY; Liu YP; Zhang J; Dong L; Lee KSS; Hammock BD; Jiang JX; Guan CX
Shock; 2017 May; 47(5):638-645. PubMed ID: 27753791
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
[TBL] [Abstract][Full Text] [Related]
14. 4-PBA inhibits LPS-induced inflammation through regulating ER stress and autophagy in acute lung injury models.
Zeng M; Sang W; Chen S; Chen R; Zhang H; Xue F; Li Z; Liu Y; Gong Y; Zhang H; Kong X
Toxicol Lett; 2017 Apr; 271():26-37. PubMed ID: 28245985
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis novel di-carbonyl analogs of curcumin (DACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI).
Qian J; Chen X; Shu S; Zhang W; Fang B; Chen X; Zhao Y; Liu Z; Liang G
Eur J Med Chem; 2019 Apr; 167():414-425. PubMed ID: 30780088
[TBL] [Abstract][Full Text] [Related]
16. Design and Optimization of 3'-(Imidazo[1,2-
Mo C; Zhang Z; Li Y; Huang M; Zou J; Luo J; Tu ZC; Xu Y; Ren X; Ding K; Lu X
ACS Med Chem Lett; 2020 Mar; 11(3):379-384. PubMed ID: 32184973
[TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors.
Gao M; Duan L; Luo J; Zhang L; Lu X; Zhang Y; Zhang Z; Tu Z; Xu Y; Ren X; Ding K
J Med Chem; 2013 Apr; 56(8):3281-95. PubMed ID: 23521020
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
20. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
